Who Paid My Doc
Daria Canale
Registered Nurse, Emergency Philadelphia, PA Nurse Practitioner
NPI 1336478726 CMS profile 11061137
10800 Knights Rd, Philadelphia, PA 19114
General payments
$111
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Daria Canale of Philadelphia, PA is reported in the CMS Open Payments database as having received $111 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $16 | 1 | |
| 2021 | General | $96 | 6 |
Beside peers
- Daria Canale
- Registered Nurse, Emergency median
- Middle half of Registered Nurse, Emergency
- National median
In program year 2025, general payments to Daria Canale were reported at $0. Among 48 Registered Nurse, Emergency profiles paid that year, the median was $76 and the middle half received between $24 and $215.
Show as a table
| Year | Daria Canale | Registered Nurse, Emergency median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $96 | — | — | $132 |
| 2022 | $16 | $56 | $19–$124 | $149 |
| 2023 | $0 | — | — | $160 |
| 2024 | $0 | $78 | $25–$107 | $164 |
| 2025 | $0 | $76 | $24–$215 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 3 drugsPart D claims
42
Drug cost
$190
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Mupirocin | Generic | 11 | $84 | |
| Cephalexin | Generic | 12 | $74 | |
| Prednisone | Generic | 19 | $32 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 26 billing codesPaid by Medicare
$4,778
Medicare patients
55
Services billed
106
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 47% | |
| Diabetes | 36% | |
| Ischemic heart disease | 31% | |
| Chronic kidney disease | 31% | |
| COPD | 22% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Registered Nurse, Emergency in Pennsylvania
Related records
Registered Nurse, Emergency in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Registered Nurse, Emergency
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.